Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial
Version 3 2024-06-20, 01:18Version 3 2024-06-20, 01:18
Version 2 2024-05-30, 15:12Version 2 2024-05-30, 15:12
Version 1 2014-10-28, 09:44Version 1 2014-10-28, 09:44
journal contribution
posted on 2024-06-20, 01:18 authored by Michael BerkMichael Berk, Olivia DeanOlivia Dean, SM Cotton, CS Gama, F Kapczinski, B Fernandes, K Kohlmann, S Jeavons, K Hewitt, K Moss, C Allwang, I Schapkaitz, H Cobb, AI Bush, Seetal DoddSeetal Dodd, GS MalhiMaintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial
History
Journal
BMC MedicineVolume
10Article number
ARTN 91Pagination
1 - 11Location
EnglandPublisher DOI
Open access
- Yes
ISSN
1741-7015eISSN
1741-7015Language
EnglishNotes
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Publication classification
C1 Refereed article in a scholarly journalCopyright notice
2012, Berk et al.Issue
1Publisher
BMCPublication URL
Usage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineMedicine, General & InternalGeneral & Internal MedicineN-acetyl cysteinedepressionbipolar disordermaintenancemaniaoxidativeOXIDATIVE STRESSRATING-SCALEDSM-IVACETYLCYSTEINEGLUTATHIONEDEPRESSIONLITHIUMSCHIZOPHRENIAANTIOXIDANTVALIDATION119999 Medical and Health Sciences not elsewhere classified970111 Expanding Knowledge in the Medical and Health Sciences
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC